8,110 results match your criteria: "Germany T.P.; and AOK Research Institute WIdO[Affiliation]"

Background: Atrial fibrillation (AF) and flutter (AFl) increase the risk of thromboembolism. The aim of the study was to assess the prevalence of left atrial thrombus (LAT) in AF/AFl in relation to oral anticoagulation (OAC). Methods: LATTEE (NCT03591627) was a multicenter, prospective, observational study enrolling consecutive patients with AF/AFl referred for transesophageal echocardiography before cardioversion or ablation.

View Article and Find Full Text PDF

Background EAST-AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial) demonstrated clinical benefit of early rhythm-control therapy (ERC) in patients with new-onset atrial fibrillation (AF) and concomitant cardiovascular conditions compared with current guideline-based practice. This study aimed to evaluate the generalizability of EAST-AFNET 4 in routine practice. Methods and Results Using a US administrative database, we identified 109 739 patients with newly diagnosed AF during the enrollment period of EAST-AFNET 4.

View Article and Find Full Text PDF

Background: The insulin-like growth factor 1 (IGF1) pathway is a key regulator of cellular metabolism and aging. Although its inhibition promotes longevity across species, the effect of attenuated IGF1 signaling on cardiac aging remains controversial.

Methods: We performed a lifelong study to assess cardiac health and lifespan in 2 cardiomyocyte-specific transgenic mouse models with enhanced versus reduced IGF1 receptor (IGF1R) signaling.

View Article and Find Full Text PDF

Training accurate and robust machine learning models requires a large amount of data that is usually scattered across data silos. Sharing or centralizing the data of different healthcare institutions is, however, unfeasible or prohibitively difficult due to privacy regulations. In this work, we address this problem by using a privacy-preserving federated learning-based approach, , for complex models such as convolutional neural networks.

View Article and Find Full Text PDF

Prevalence and Significance of the Vessel-Cluster Sign on Susceptibility-Weighted Imaging in Patients With Severe Small Vessel Disease.

Neurology

August 2022

From the Comprehensive Stroke Center (S.R.), Department of Neuroscience, Hospital Clinic, University of Barcelona; August Pi i Sunyer Biomedical Research Institute (IDIBAPS)(S.R.), Barcelona, Spain; Centre for Clinical Brain Sciences (E.C., M.S.S., M.T., F.C., G.B., D.J.G., F.D., I.H., J.M.W.), UK Dementia Research Institute, University of Edinburgh, United Kingdom; Institute for Stroke and Dementia Research (A.K., M. Dichgans), University Hospital, LMU Munich; Department of Radiology (M.I.),Ludwig-Maximilians-University Hospital Munich, Germany; Department of Neurology (D.K., J.S., R.v.O.), CARIM-School for Cardiovascular Diseases Maastricht University Medical Center+, Maastricht,; Department of Radiology & Nuclear Medicine (W.H.B.), School for Mental Health & Neuroscience and School for Cardiovascular Diseases, Maastricht University Medical Centre, Netherlands; Institute for Stroke and Dementia Research (ISD) (M. Duering), University Hospital, LMU Munich, Germany; Medical Image Analysis Center (MIAC AG) and Department of Biomedical Engineering (M. Duering), University of Basel, Switzerland; Munich Cluster for Systems Neurology (SyNergy) (M. Dichgans); and German Center for Neurodegenerative Diseases (DZNE) (M. Dichgans), Munich, Germany.

Background And Objectives: Magnetic resonance susceptibility-weighted imaging (SWI) can identify small brain blood vessels that contain deoxygenated blood due to its induced magnetic field disturbance. We observed focal clusters of possible dilated small vessels on SWI in white matter in severe small vessel disease (SVD). We assessed their prevalence, associations with SVD lesions, and vascular reactivity in patients with sporadic SVD and in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

View Article and Find Full Text PDF

Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement.

Am J Ophthalmol

September 2022

From the Department of Drug Design and Pharmacology, University of Copenhagen (A.-S.T., A.H., M.K.), Copenhagen, Denmark; Department of Ophthalmology, Copenhagen University Hospital, Rigshospitalet (A.H., S.H., M.K.), Glostrup, Denmark. Electronic address:

Purpose: The purpose of this study is to establish consensus among experts on outcomes and methods to be used in clinical trials to assess adverse effects of anti-glaucomatous eye drops.

Design: Modified Delphi method.

Methods: Clinical experts from Europe, North America, South America, the Middle East, and Asia were invited to participate in 2 sequential web-based surveys administered from June 27 to August 29, 2021.

View Article and Find Full Text PDF

The digestive protease chymotrypsin C (CTRC) protects the pancreas against pancreatitis by degrading potentially harmful trypsinogen. Loss-of-function genetic variants in CTRC increase risk for chronic pancreatitis (CP) with variable effect size, as judged by the reported odds ratio (OR) values. Here, we performed a meta-analysis of published studies on four variants that alter the CTRC amino-acid sequence, are clinically relatively common (global carrier frequency in CP >1%), reproducibly showed association with CP and their loss of function phenotype was verified experimentally.

View Article and Find Full Text PDF

Background: Spastic paraplegia type 7 (SPG7) mutations can present either as a pure form or a complex phenotype with movement disorders.

Objective: Describe the main features of subjects with SPG7 mutations associated with movement disorders.

Methods: We analyzed the clinical and paraclinical information of subjects with SPG7 mutations associated with movement disorders.

View Article and Find Full Text PDF

Background: Maximal left ventricular wall thickness (MLVWT) is a risk factor for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM). In adults, the severity of left ventricular hypertrophy has a nonlinear relationship with SCD, but it is not known whether the same complex relationship is seen in childhood. The aim of this study was to describe the relationship between left ventricular hypertrophy and SCD risk in a large international pediatric HCM cohort.

View Article and Find Full Text PDF

Objective: To assess the safety of empagliflozin in patients with type 2 diabetes and moderate to severe chronic kidney disease (CKD) (category G3-4) enrolled in clinical trials.

Research Design And Methods: This analysis pooled data from 19 randomized, placebo-controlled, phase 1-4 clinical trials and 1 randomized, placebo-controlled extension study in which patients received empagliflozin 10 mg or 25 mg daily. Time to first occurrence of adverse events (AEs) was evaluated using Kaplan-Meier analysis and multivariable Cox regression models.

View Article and Find Full Text PDF

Objective: Human genomics established that pathogenic variation in diverse genes can underlie a single disorder. For example, hereditary spastic paraplegia is associated with >80 genes, with frequently only few affected individuals described for each gene. Herein, we characterize a large cohort of individuals with biallelic variation in ENTPD1, a gene previously linked to spastic paraplegia 64 (Mendelian Inheritance in Man # 615683).

View Article and Find Full Text PDF

Augmented and virtual reality devices are being actively investigated and implemented for a wide range of medical uses. However, significant gaps in the evaluation of these medical devices and applications hinder their regulatory evaluation. Addressing these gaps is critical to demonstrating the devices' safety and effectiveness.

View Article and Find Full Text PDF

Context: Biomarkers that can accurately predict risk of type 1 diabetes (T1D) in genetically predisposed children can facilitate interventions to delay or prevent the disease.

Objective: This work aimed to determine if a combination of genetic, immunologic, and metabolic features, measured at infancy, can be used to predict the likelihood that a child will develop T1D by age 6 years.

Methods: Newborns with human leukocyte antigen (HLA) typing were enrolled in the prospective birth cohort of The Environmental Determinants of Diabetes in the Young (TEDDY).

View Article and Find Full Text PDF

Impact of the external school food environment on the associations of internal school food environment with high schoolers' diet and BMI.

Public Health Nutr

November 2022

Social and Behavioral Sciences Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD20817, USA.

Objective: To examine associations of school food availability with student intake frequency and BMI, and whether the number of neighbourhood food outlets modifies these associations.

Design: Baseline assessment of a nationally representative cohort study of US 10th graders. Students reported intake frequency of fruits and vegetables (FV), snacks and soda.

View Article and Find Full Text PDF

Purpose: We report a first case of bilateral occult macular dystrophy (OMD) with a c.133C>T (p.Arg45Trp) pathogenic variant in the retinitis pigmentosa 1-like 1 () gene in a patient of Caucasian Swiss decent.

View Article and Find Full Text PDF

Immunotherapy in Squamous Cell Cancer of the Esophagus.

Curr Oncol

March 2022

Hematology-Oncology Practice Eppendorf (HOPE), 20249 Hamburg, Germany.

Article Synopsis
  • Treatment of esophageal carcinoma has evolved with immunotherapy, particularly highlighting the effectiveness of PD-1 inhibitors like nivolumab and pembrolizumab in improving patient outcomes.
  • Notable trials, such as CheckMate-577 and KEYNOTE-590, show these drugs enhance disease-free survival (DFS) and overall survival (OS) in various settings, including adjuvant therapy and first-line treatment for PD-L1 positive patients.
  • Additional studies in Asian populations further reinforce these findings, demonstrating significant survival benefits from other PD-1 inhibitors combined with chemotherapy in both first-line and second-line treatment scenarios.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the genetic and environmental interactions influencing colorectal cancer risk, focusing on the J-shaped relationship with alcohol consumption, distinguishing between nondrinkers, light-to-moderate drinkers, and heavy drinkers.
  • - By pooling data from major cancer registries, the researchers identified 13 significant SNPs in the 10q24.2/COX15 region, showing that the A allele of SNP rs2300985 increases colorectal cancer risk for light-to-moderate drinkers compared to nondrinkers and heavy drinkers.
  • - The findings suggest that the strongest genetic association with colorectal cancer occurs in nondrinkers, with SNP rs1318920 predicted as a potential causal regulatory variant impacting cancer risk.
View Article and Find Full Text PDF

MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study.

Radiology

August 2022

From the Departments of Neurosurgery (M.Z., Q.Z.), Otolaryngology-Head and Neck Surgery (Q.Z.), and Pathology (S.S.A., H.V.), Stanford Hospital and Clinics, Stanford, Calif; Departments of Radiology (M.Z., K.W.Y.), Neurology (P.G.F.), and Neurosurgery (G.A.G.), Lucile Packard Children's Hospital, Stanford University, 725 Welch Rd, G516, Palo Alto, CA 94304; Department of Statistics, Stanford University, Stanford, Calif (S.W.W.); Department of Radiology (J.N.W.) and Division of Pediatric Hematology/Oncology, Department of Pediatrics (N.A.V.), Seattle Children's Hospital, Seattle, Wash; Department of Radiology, Harborview Medical Center, Seattle, Wash (J.N.W.); Departments of Diagnostic Imaging (M.W.W., S. Laughlin, B.E.W.) and Surgery (M.T.) and Division of Haematology/Oncology, Department of Pediatrics (V.R.), The Hospital for Sick Children, Toronto, Canada; Departments of Neurosurgery (S.T., K.A.), Radiology (K.M.), and Developmental Biology & Cancer (T.S.J.), Great Ormond Street Institute of Child Health, London, UK; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pa (M.H.); Stanford School of Medicine, Stanford University, Stanford, Calif (L.T.T.); Departments of Radiology (K.S., M.M.) and Neurosurgery (S.H.), Duke Children's Hospital & Health Center, Durham, NC; Department of Physiology and Nutrition, University of Colorado-Colorado Springs, Colorado Springs, Colo (S. Lummus); Department of Radiology, Children's Hospital of Orange County, Orange, Calif (H.L., A.E.); Department of Radiology, New York University Grossman School of Medicine, New York, NY (A.R.); Division of Pediatric Neurosurgery, Department of Neurosurgery, and Huntsman Cancer Institute, University of Utah School of Medicine, Intermountain Healthcare Primary Children's Hospital, Salt Lake City, Utah (J.N., S.H.C., E.T.); Division of Child Neurology, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, Canada (S. Perreault); Department of Clinical Radiology & Imaging Sciences, Riley Children's Hospital, Indianapolis, Ind (K.R.M.B., C.Y.H.); Division of Neurosurgery, Dayton Children's Hospital, Dayton, Ohio (R.M.L.); Department of Pediatrics, Doernbecher Children's Hospital, Portland, Ore (Y.J.C.); Department of Radiology, Boston Children's Hospital, Boston, Mass (T.P.); Department of Pediatrics, Hopp Children's Cancer Center, Heidelberg, Germany (S. Pfister); and Department of Medical Imaging, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill (A.J.).

Background Radiogenomics of pediatric medulloblastoma (MB) offers an opportunity for MB risk stratification, which may aid therapeutic decision making, family counseling, and selection of patient groups suitable for targeted genetic analysis. Purpose To develop machine learning strategies that identify the four clinically significant MB molecular subgroups. Materials and Methods In this retrospective study, consecutive pediatric patients with newly diagnosed MB at MRI at 12 international pediatric sites between July 1997 and May 2020 were identified.

View Article and Find Full Text PDF

Introduction: There is an urgent need to reduce the burden of non-communicable diseases (NCDs), particularly in low-and middle-income countries, where the greatest burden lies. Yet, there is little research concerning the specific issues involved in scaling up NCD interventions targeting low-resource settings. We propose to examine this gap in up to 27 collaborative projects, which were funded by the Global Alliance for Chronic Diseases (GACD) 2019 Scale Up Call, reflecting a total funding investment of approximately US$50 million.

View Article and Find Full Text PDF

Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.

Circulation

April 2022

Cardiac Intensive Care Unit, Medizinische Klinik und Poliklinik I (E.L., A.K., K.K., L.B., C.S., S.F., T.P., D.B., S.B., J.H., S.M., M.O.), Klinikum der Universität München, and German Center for Cardiovascular Research, partner site Munich Heart Alliance.

The Impella device (Impella, Abiomed, Danvers, MA) is a percutaneous transvalvular microaxial flow pump that is currently used for (1) cardiogenic shock, (2) left ventricular unloading (combination of venoarterial extracorporeal membrane oxygenation and Impella concept), (3) high-risk percutaneous coronary interventions, (4) ablation of ventricular tachycardia, and (5) treatment of right ventricular failure. Impella-assisted forward blood flow increased mean arterial pressure and cardiac output, peripheral tissue perfusion, and coronary blood flow in observational studies and some randomized trials. However, because of the need for large-bore femoral access (14 F for the commonly used Impella CP device) and anticoagulation, the incidences of bleeding and ischemic complications are as much as 44% and 18%, respectively.

View Article and Find Full Text PDF

Quadruple genetic variants in a sporadic ALS patient.

Mol Genet Genomic Med

July 2022

Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany.

Objectives: Due to upcoming gene-specific therapy approaches for ALS patients, understanding familial and sporadic ALS genetics is becoming increasingly important. In this study, we wanted to investigate underlying genetic causes for an SALS patient.

Methods: We performed ALS gene panel sequencing and subsequent segregation analysis in the family.

View Article and Find Full Text PDF

Collaborative Hubs: Making the Most of Predictive Epidemic Modeling.

Am J Public Health

June 2022

Nicholas G. Reich and Evan L. Ray are with the Department of Biostatistics and Epidemiology, University of Massachusetts-Amherst. Justin Lessler is with the Department of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill. Sebastian Funk is with the Centre for Mathematical Modelling of Infectious Diseases and Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK. Cecile Viboud is with the Fogarty International Center, National Institutes of Health, Bethesda, MD. Alessandro Vespignani is with the Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA. Ryan J. Tibshirani is with the Department of Statistics & Data Science and the Department of Machine Learning, Carnegie Mellon University, Pittsburgh, PA. Katriona Shea and Rebecca K. Borchering are with the Department of Biology and Center for Infectious Disease Dynamics, The Pennsylvania State University, University Park. Melanie Schienle and Johannes Bracher are with the Chair of Statistics and Econometrics, Karlsruhe Institute of Technology, Karlsruhe, Germany. Michael C. Runge is with the Eastern Ecological Science Center, US Geological Survey, Laurel, MD. Roni Rosenfeld is with the Machine Learning Department, Carnegie Mellon University. Rene Niehus and Helen C. Johnson are with the European Centre for Disease Prevention and Control, Solna, Sweden. Michael A. Johansson and Matthew Biggerstaff are with the COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, GA. Harry Hochheiser is with the Department of Biomedical Informatics and Intelligent Systems Program, University of Pittsburgh, Pittsburgh, PA. Lauren Gardner is with the Department of Civil and Systems Engineering, Johns Hopkins University, Baltimore, MD.

View Article and Find Full Text PDF
Article Synopsis
  • * Through analysis of over 9 million genetic variants, the researchers found that none showed a significant interaction with MHT use for breast cancer risk, indicating common genetic variations do not heavily influence this association.
  • * The strongest evidence of interaction was linked to a specific genetic variant, but overall findings suggest MHT's effect on breast cancer risk is primarily not affected by common genetic factors.
View Article and Find Full Text PDF
Article Synopsis
  • Global genomic surveillance has found a new SARS-CoV-2 variant, C.1.2, in South Africa and eleven other countries, which shows increased transmissibility and potentially greater disease severity.
  • C.1.2 has a high substitution rate in its spike protein, related to reduced neutralization sensitivity, making it harder for antibodies from vaccinated individuals or those infected with earlier strains to effectively combat it.
  • Previous infections with variants Beta or Delta may provide some protection against C.1.2, suggesting that the vaccine's effectiveness against this new variant could be similar to that against the earlier concerning variants.
View Article and Find Full Text PDF

Background And Aims: A variant (p.Arg225Trp) of peroxisomal acyl-CoA oxidase 2 (ACOX2), involved in bile acid (BA) side-chain shortening, has been associated with unexplained persistent hypertransaminasemia and accumulation of C27-BAs, mainly 3α,7α,12α-trihydroxy-5β-cholestanoic acid (THCA). We aimed to investigate the prevalence of ACOX2 deficiency-associated hypertransaminasemia (ADAH), its response to ursodeoxycholic acid (UDCA), elucidate its pathophysiological mechanism and identify other inborn errors that could cause this alteration.

View Article and Find Full Text PDF